Endpoint Clinical is a pioneering Interactive Response Technology (IRT) systems and solutions provider catering to the life sciences industry. Established in 2009, the company is committed to assisting Sponsors in achieving clinical trial success. Their flagship IRT solution, PULSE ®, facilitates patient randomization and management, site management, and drug supply management while their clinical supplies management tool, DRIVE, optimizes the supply chain, reduces operational costs, and ensures accurate patient dosing. With the headquarters in the Boston area and subsidiaries across the US, EU, and Asia, Endpoint Clinical has attracted a $1.70M Debt Financing investment on 01 March 2010. This investment underscores the confidence in their customer-obsessed team and suite of technologies and reinforces their potential for growth and influence within the industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | $1.70M | - | 01 Mar 2010 |
No recent news or press coverage available for Endpoint Clinical.